Indians Pharmacare Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 12-12-2024
- Paid Up Capital ₹ 1.20 M
as on 12-12-2024
- Company Age 13 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 M
as on 12-12-2024
- Revenue 3.82%
(FY 2016)
- Profit -15.65%
(FY 2016)
- Ebitda -14.04%
(FY 2016)
- Net Worth -9.52%
(FY 2016)
- Total Assets -18.54%
(FY 2016)
About Indians Pharmacare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.20 M.
The company currently has active open charges totaling ₹2.00 M.
Mukta Agarwal and Amit Kumar serve as directors at the Company.
- CIN/LLPIN
U74120UP2011PTC045747
- Company No.
045747
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jul 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Meerut, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Indians Pharmacare Private Limited offer?
Indians Pharmacare Private Limited offers a wide range of products and services, including Animal Medicines & Health Care, Animal Nutraceuticals, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Veterinary Medicines, Antibiotic Injection, Ceftriaxone and Sulbactam Injection, Pain Killers, Forte Tablets, Veterinary Injections.
Who are the key members and board of directors at Indians Pharmacare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukta Agarwal  | Director | 02-Jul-2012 | Current |
| Amit Kumar | Director | 15-Jul-2011 | Current |
Financial Performance of Indians Pharmacare.
Indians Pharmacare Private Limited, for the financial year ended 2016, experienced modest growth in revenue, with a 3.82% increase. The company also saw a substantial fall in profitability, with a 15.65% decrease in profit. The company's net worth dipped by a decrease of 9.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indians Pharmacare?
In 2017, Indians Pharmacare had a promoter holding of 16.67% and a public holding of 83.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Earth Care ( India ) Private LimitedActive 13 years 5 monthsMukta Agarwal and Amit Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 17 Jul 2012 | ₹2.00 M | Open |
How Many Employees Work at Indians Pharmacare?
Unlock and access historical data on people associated with Indians Pharmacare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indians Pharmacare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indians Pharmacare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
